These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9733216)

  • 21. Apolipoprotein E phenotype modifies metabolic and hemodynamic abnormalities related to central obesity in women.
    Uusitupa MI; Karhunen L; Rissanen A; Franssila-Kallunki A; Niskanen L; Kervinen K; Kesäniemi YA
    Am J Clin Nutr; 1996 Aug; 64(2):131-6. PubMed ID: 8694011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipoprotein metabolism in postmenopausal and oophorectomized women.
    Wakatsuki A; Sagara Y
    Obstet Gynecol; 1995 Apr; 85(4):523-8. PubMed ID: 7898827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apolipoprotein E polymorphism modulates the association between obesity and dyslipidemias during young adulthood: The Bogalusa Heart Study.
    Srinivasan SR; Ehnholm C; Elkasabany A; Berenson GS
    Metabolism; 2001 Jun; 50(6):696-702. PubMed ID: 11398147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of hormone replacement therapy and hepatic lipase polymorphism on serum lipid profiles in postmenopausal Japanese women.
    Somekawa Y; Umeki H; Kobayashi K; Tomura S; Aso T; Hamaguchi H
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4766-70. PubMed ID: 12364471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LDL molecular size as risk factor in coronary artery disease.
    Kozma L; Fodor J; Chockalingam A; Sussex B
    Acta Med Hung; 1992-1993; 49(1-2):65-77. PubMed ID: 1296188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating oxidized LDL is associated with parameters of the metabolic syndrome in postmenopausal women.
    Lapointe A; Couillard C; Piché ME; Weisnagel SJ; Bergeron J; Nadeau A; Lemieux S
    Atherosclerosis; 2007 Apr; 191(2):362-8. PubMed ID: 16677652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in low density lipoprotein subfractions and apolipoproteins in premenopausal and postmenopausal women.
    Campos H; McNamara JR; Wilson PW; Ordovas JM; Schaefer EJ
    J Clin Endocrinol Metab; 1988 Jul; 67(1):30-5. PubMed ID: 3379134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-HDL-cholesterol and apolipoprotein B compared with LDL-cholesterol in atherosclerotic cardiovascular disease risk assessment.
    Carr SS; Hooper AJ; Sullivan DR; Burnett JR
    Pathology; 2019 Feb; 51(2):148-154. PubMed ID: 30595507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased HDL2 and HDL3 cholesterol, Apo A-I and Apo A-II, and increased risk of myocardial infarction.
    Buring JE; O'Connor GT; Goldhaber SZ; Rosner B; Herbert PN; Blum CB; Breslow JL; Hennekens CH
    Circulation; 1992 Jan; 85(1):22-9. PubMed ID: 1728453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
    Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
    Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantification of apolipoprotein AI-containing lipoprotein particles in non-insulin-dependent diabetes mellitus.
    Contiero E; Ferrari R; Vaselli GM; Folin M
    Diabetes Res Clin Pract; 1998 Mar; 39(3):201-9. PubMed ID: 9649952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum lipoproteins improve after successful pharmacologic antidepressant treatment: a randomized open-label prospective trial.
    Hummel J; Westphal S; Weber-Hamann B; Gilles M; Lederbogen F; Angermeier T; Luley C; Deuschle M; Kopf D
    J Clin Psychiatry; 2011 Jul; 72(7):885-91. PubMed ID: 21294998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The apoB-100 gene EcoRI polymorphism influences the relationship between features of the insulin resistance syndrome and the hyper-apoB and dense LDL phenotype in men.
    Vohl MC; Tchernof A; Dionne FT; Moorjani S; Prud'homme D; Bouchard C; Nadeau A; Lupien PJ; Després JP
    Diabetes; 1996 Oct; 45(10):1405-11. PubMed ID: 8826978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of high density lipoprotein (HDL)-associated sphingosine 1-phosphate with serum levels of HDL-cholesterol and apolipoproteins.
    Zhang B; Tomura H; Kuwabara A; Kimura T; Miura S; Noda K; Okajima F; Saku K
    Atherosclerosis; 2005 Jan; 178(1):199-205. PubMed ID: 15585219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relation of apolipoprotein E polymorphism to multiple cardiovascular risk in children: the Bogalusa Heart Study.
    Srinivasan SR; Ehnholm C; Wattigney WA; Bao W; Berenson GS
    Atherosclerosis; 1996 Jun; 123(1-2):33-42. PubMed ID: 8782835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dietary fat saturation affects apolipoprotein AII levels and HDL composition in postmenopausal women.
    Sánchez-Muniz FJ; Merinero MC; Rodríguez-Gil S; Ordovas JM; Ródenas S; Cuesta C
    J Nutr; 2002 Jan; 132(1):50-4. PubMed ID: 11773507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relevance of a protein-enriched low density lipoprotein as a risk for coronary heart disease in relation to other known risk factors.
    Swinkels DW; Demacker PN; Hendriks JC; Brenninkmeijer BJ; Stuyt PM
    Atherosclerosis; 1989 May; 77(1):59-67. PubMed ID: 2719763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of apolipoprotein E polymorphism on serum lipids and lipoprotein changes from childhood to adulthood: the Bogalusa Heart Study.
    Srinivasan SR; Ehnholm C; Elkasabany A; Berenson G
    Atherosclerosis; 1999 Apr; 143(2):435-43. PubMed ID: 10217374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relative effects of obesity and insulin resistance on cardiovascular risk factors in nondiabetic and normotensive men.
    Park SH; Lee WY; Lee YS; Rhee EJ; Kim SW
    Korean J Intern Med; 2004 Jun; 19(2):75-80. PubMed ID: 15366636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of apolipoprotein (Apo)E genotype with plasma apo E levels.
    Larson IA; Ordovas JM; DeLuca C; Barnard JR; Feussner G; Schaefer EJ
    Atherosclerosis; 2000 Feb; 148(2):327-35. PubMed ID: 10657569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.